Datelliptium chloride
Alternative Names: Detalliptinium; DTL; NSC 311152; SR 95156BLatest Information Update: 26 Jul 1994
At a glance
- Originator Sanofi-Synthelabo
- Class Alkaloids; Antineoplastics
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer